Assessing the Frequency of COVID-19 in Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)

M Zahedi, F Davanloo - Cardiovascular & Haematological …, 2023 - ingentaconnect.com
Background: The COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a global health crisis with significant morbidity …

Is there any effect of COVID-19 mRNA vaccination on electrocardiographic parameters in patients without apparent cardiovascular disease?

A Küp, M Çelik, A Uslu, Ş Külahçıoğlu… - Troia Medical …, 2022 - dergipark.org.tr
Objective: Electrocardiographic alterations were investigated following the second dosage
of COVID-19 mRNA vaccination. Methods: A total of 260 individuals after two doses of …

Predictores de ventilación mecánica en pacientes con diagnóstico de Covid-19 en el Hospital II Essalud-Cajamarca, periodo febrero–abril 2021

Q Estacio, D Omar - 2022 - 190.116.36.86
OBJETIVO: Establecer factores predictores para requerimiento de ventilación mecánica en
pacientes con covid-19 del Hospital II Essalud de Cajamarca durante el periodo del 1 de …

COVID-19 And Cardiovascular Diseases: A Scoping Review

SA Mahkooyeh, M Shahmari, F Molayi… - International Journal of …, 2023 - intjmi.com
Coronavirus disease is an emergency condition worldwide that can affect various organs.
This scoping review intended to categorize the current evidence of the relationship of the …

Deep Learning for ECG Image Analysis: A Lightweight Approach for Covid-19 Diagnosis

AH El-Naggar, SA Fawzi… - … Conference on Machine …, 2024 - ieeexplore.ieee.org
Since late 2019, Covid-19 has broken out causing immense pressure on healthcare systems
worldwide. Fast detection of Covid-19 has become crucial in controlling and slow-pacing the …

miRNAomics in COVID-19

B Kaur, J Kaur - Omics approaches and technologies in COVID-19, 2023 - Elsevier
Coronavirus disease 2019 or COVID-19 has surfaced as a global disaster eliciting severe
respiratory illness, imputable to severe acute respiratory syndrome coronavirus 2 (SARS …

FUTURE PROGNOSIS FOR CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH SARS-COV-2: A PHARMACOLOGICAL AND MOLECULAR PERSPECTIVE

AV PR, SP Ranjith - Authorea Preprints, 2023 - essopenarchive.org
Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
caused the coronavirus disease 2019 (COVID-19), which is associated with cardiovascular …

Drug‐induced QTc interval prolongation in PCR‐positive non‐ICU COVID‐19 patients with diverse findings on chest computed tomography

F Ozyurtlu, N Cetin, V Yavuz - International Journal of Clinical …, 2021 - Wiley Online Library
Background Some of the drugs used for the treatment of coronavirus disease (COVID‐19)
can increase the risk of corrected QT (QTc) interval prolongation, which may trigger …

A bird's eye view of the COVID-19 pandemic in India: The past, present, and future

DS Gupta, M Aswar, MS Kumar - International and Life Course Aspects of …, 2024 - Elsevier
The COVID-19 pandemic triggered an unprecedented wave of challenges across the globe,
exposing several lacunae in healthcare systems and highlighting potentials for …

[PDF][PDF] Role of ACE-2 Receptors in Multi-System-ic Manifestations of COVID-19

A Mehmood - Clin Surg, 2023 - researchgate.net
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which was first
discovered in late 2019, is currently wreaking havoc around the world. The most common …